Showing 1 - 1 results of 1 for search '"вакцин-индуцированная иммунная тромботическая тромбоцитопения"', query time: 0.47s Refine Results
  1. 1
    Academic Journal

    Source: Obstetrics, Gynecology and Reproduction; Vol 18, No 6 (2024); 908-918 ; Акушерство, Гинекология и Репродукция; Vol 18, No 6 (2024); 908-918 ; 2500-3194 ; 2313-7347

    File Description: application/pdf

    Relation: https://www.gynecology.su/jour/article/view/2292/1284; https://www.gynecology.su/jour/article/view/2292/1288; WHO Health Emergencies Programme. Number of COVID-19 cases reported to WHO (cumulative total). WHO COVID-19 dashboard. World Health Organization, 2024. Режим доступа: https://data.who.int/dashboards/covid19/cases. [Дата обращения: 25.11.2024].; Leung T.Y.M., Chan A.Y.L., Chan E.W. et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg Microbes Infect. 2020;9(1):2190-9. https://doi.org/10.1080/22221751.2020.1825914.; Jenner W.J., Kanji R., Mirsadraee S. et al. Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review. J Thromb Thrombolysis. 2021;51(3):595-607. https://doi.org/10.1007/s11239-021-02394-7.; Lillicrap D., Morrissey J.H. 2020 - Year of COVID-19. J Thromb Haemost. 2020;18(9):2081. https://doi.org/10.1111/jth.15041.; Cattaneo M., Bertinato E.M., Birocchi S. et al. Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified? Thromb Haemost. 2020;120(8):1230-2. https://doi.org/10.1055/s-0040-1712097.; Ackermann M., Verleden S.E., Kuehnel M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120-8. https://doi.org/10.1056/NEJMoa2015432.; Макацария А.Д., Бицадзе В.О., Хизроева Д.Х. Катастрофический антифосфолипидный синдром и тромботический "шторм". Сибирский медицинский журнал. 2010;25(4-2):118-23.; Макацария А.Д., Григорьева К.Н., Мингалимов М.А. и др. Коронавирусная инфекция (COVID-19) и синдром диссеминированного внутрисосудистого свертывания. Акушерство, Гинекология и Репродукция. 2020;14(2):123-31. https://doi.org/10.17749/2313-7347.132.; Popescu N.I., Lupu C., Lupu F. Disseminated intravascular coagulation and its immune mechanisms. Blood. 2022;139(13):1973-86. https://doi.org/10.1182/blood.2020007208.; Iba T., Levi M., Thachil J., Levy J.H. Disseminated intravascular coagulation: the past, present, and future considerations. Semin Thromb Hemost. 2022;48(8):978-87. https://doi.org/10.1055/s-0042-1756300.; Makatsariya A.D., Slukhanchuk E.V., Bitsadze V.O. et al. Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state. J Matern Fetal Neonatal Med. 2022;35(13):2536-44. https://doi.org/10.1080/14767058.2020.1786811.; Wyrick-Glatzel J. Thrombotic thrombocytopenic purpura and ADAMTS-13: new insights into pathogenesis, diagnosis, and therapy. Laboratory Medicine. 2004;35(12):733-9. https://doi.org/10.1309/77KRKLJW0EA75T2R.; Tsai H.M. Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol. 2010;91(1):1-19. https://doi.org/10.1007/s12185-009-0476-1.; Макацария А.Д., Хизроева Д.Х., Шенфельд И. и др. Фактор фон Виллебранда и миелопероксидаза как лабораторные предикторы выживаемости при тяжелом течении COVID-19. Вестник Российской академии медицинских наук. 2022;77(3):189-98. https://doi.org/10.15690/vramn2094.; Бицадзе В.О., Хизроева Д.Х., Гри Ж.-К. и др. Патогенетическое и прогностическое значение воспаления и нарушений в оси ADAMTS-13/vWF у больных тяжелой формой COVID-19. Акушерство, Гинекология и Репродукция. 2022;16(3):228-43. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2022.327.; Ortel T.L., Kitchens C.S., Erkan D. et al. Clinical causes and treatment of the thrombotic storm. Expert Rev Hematol. 2012;5(6):653-9. https://doi.org/10.1586/ehm.12.56.; Libby P., Simon D.I. Inflammation and thrombosis: the clot thickens. Circulation. 2001;103(13):1718-20. https://doi.org/10.1161/01.cir.103.13.1718.; Tanguay J.F., Geoffroy P., Dorval J.F., Sirois M.G. Percutaneous endoluminal arterial cryoenergy improves vascular remodelling after angioplasty. Thromb Haemost. 2004;92(5):1114-21. https://doi.org/10.1160/TH04-06-0336.; Blair P., Rex S., Vitseva O. et al. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res. 2009;104(3):346-54. https://doi.org/10.1161/CIRCRESAHA.108.185785.; Schrottmaier W.C., Assinger A. The concept of thromboinflammation. Hamostaseologie. 2024;44(1):21-30. https://doi.org/10.1055/a-2178-6491.; Ammollo C.T., Semeraro F., Bison E. et al. Patients with antiphospholipid syndrome display a marked resistance to the profibrinolytic activity of anticoagulants. ISTH Academy, December 2, 2024. Режим доступа: https://academy.isth.org/isth/2020/milan/297022/mario.colucci.patients.with.antiphospholipid.syndrome.display.a.marked.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dammollo. [Дата обращения: 25.11.2024].; Pavord S., Hunt B.J., Horner D. et al.; Guideline Committee. Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance. BMJ. 2021;375:n2195. https://doi.org/10.1136/bmj.n2195.; Warkentin T. Anti-PF4 antibody-mediated thrombosis disorders: HIT, aHIT, SpHIT. ISTH Academy, December 3, 2024. Режим доступа: https://academy.isth.org/isth/2024/isth-2024-congress/4137061/theodore.28ted29.warkentin.anti-pf4.antibody-mediated.thrombosis.disorders.hit.html?f=menu%3D3%2Abrowseby%3D8%2Asortby%3D2%2Amedia%3D1%2Atopic%3D21415. [Дата обращения: 25.11.2024].; Warkentin T.E. Platelet-activating anti-PF4 disorders: An overview. Semin Hematol. 2022;59(2):59-71. https://doi.org/10.1053/j.seminhematol.2022.02.005.; Nicolai L., Kaiser R., Stark K. Thromboinflammation in long COVID - the elusive key to postinfection sequelae? J Thromb Haemost. 2023;21(8):2020-31. https://doi.org/10.1016/j.jtha.2023.04.039.; https://www.gynecology.su/jour/article/view/2292